Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7171456)

  • 1. Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer.
    Staab HJ; Anderer FA; Hornung A; Stumpf E; Fischer R
    Br J Cancer; 1982 Nov; 46(5):773-81. PubMed ID: 7171456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The doubling time of circulating CEA as an individual prognostic criterion of recurrence in patients with gastrointestinal cancers].
    Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
    Klin Wochenschr; 1986 Jan; 64(2):63-9. PubMed ID: 3951166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease.
    Staab HJ; Anderer FA
    Cancer Detect Prev; 1983; 6(1-2):33-9. PubMed ID: 6883391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy].
    Takesue F; Inutsuka S; Nagahama S; Kusumoto H; Korenaga D; Maekawa S; Ikeda T
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
    Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
    Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas.
    Umehara Y; Kimura T; Yoshida M; Oba N; Harada Y
    Cancer; 1993 Jun; 71(12):4055-9. PubMed ID: 8508370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
    Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
    Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
    Jubert AV; Talbott TM; Maycroft TM
    Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma.
    Ito K; Hibi K; Ando H; Hidemura K; Yamazaki T; Akiyama S; Nakao A
    Jpn J Clin Oncol; 2002 Feb; 32(2):54-8. PubMed ID: 11948229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
    Armitage NC; Davidson A; Tsikos D; Wood CB
    Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.
    Boey J; Cheung HC; Lai CK; Wong J
    World J Surg; 1984 Jun; 8(3):279-86. PubMed ID: 6464483
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival.
    Aabo K; Pedersen H; Kjaer M
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):211-7. PubMed ID: 3699082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
    Terabe K; Ichihashi H; Kamei H; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEA levels at recurrence and metastases; importance for detecting secondary disease.
    Rieger A; Wahren B
    Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CEA assays in postoperative detection of recurrent colorectal carcinoma (author's transl)].
    Kato K; Morimoto T; Kato T; Yasue M; Takagi H; Kito T; Nakazato H; Miyaishi S; Yamada E; Kuwabara M; Suchi T
    Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1137-42. PubMed ID: 7229472
    [No Abstract]   [Full Text] [Related]  

  • 19. Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer.
    Tanaka K; Noura S; Ohue M; Seki Y; Yamada T; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Murata K; Kameyama M; Imaoka S
    Dig Surg; 2008; 25(4):319-24. PubMed ID: 18818499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
    Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
    Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.